16:37:01 EDT Tue 18 May 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:DECN from 2020-05-19 to 2021-05-18 - 51 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-03-12 04:10U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-03-03 01:20U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-03-03 01:20U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-02-24 09:00U:DECNNews ReleaseDECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Decision Diagnostics Corp.
2021-02-23 21:15U:DECNNews ReleaseROSEN, RESPECTED INVESTOR COUNSEL, Encourages Decision Diagnostics Corp. Investors With Losses in Excess of $500K to Secure Counsel Before Important Deadline - DECN
2021-02-18 23:21U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-02-17 11:38U:DECNNews ReleaseSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
2021-02-03 20:30U:DECNNews ReleaseBREAKING NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Decision Diagnostics Corp. Investors with Large Losses to Secure Counsel Before Important Deadline - DECN
2021-02-03 08:31U:DECNNews ReleaseINVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
2021-01-31 05:13U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-01-31 05:00U:DECNNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Decision Diagnostics Corporation of Class Action Lawsuit and Upcoming Deadline - DECN
2021-01-30 18:45U:DECNNews ReleaseBREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages Decision Diagnostics Corp. Investors with Large Losses to Secure Counsel Before Important Deadline – DECN
2021-01-27 11:00U:DECNNews ReleaseDECN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm
2021-01-22 07:00U:DECNNews ReleaseDECISION DIAGNOSTICS CORP. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a federal securities class action lawsuit against Decision Diagnostics Corp.
2021-01-19 10:10U:DECNNews ReleaseDECN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm
2021-01-19 09:29U:DECNNews ReleaseSHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
2021-01-18 12:24U:DECNNews ReleaseROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Decision Diagnostics Corp. – DECN
2021-01-16 15:36U:DECNNews ReleaseSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
2021-01-15 23:48U:DECNNews ReleasePomerantz Law Firm Announces the Filing of a Class Action against Decision Diagnostics Corporation and Certain Officers - DECN
2021-01-15 23:48U:DECNNews ReleasePomerantz Law Firm Announces the Filing of a Class Action against Decision Diagnostics Corporation and Certain Officers - DECN
2020-12-21 14:07U:DECNNews ReleaseDECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit
2020-12-18 21:17U:DECNNews ReleaseDECN Comments on Recent Legal Filings by Federal Agencies
2020-12-16 09:16U:DECNNews ReleaseDECN Provides Testing Update for US, Korea and XPRIZE With Plans for Walk-in Donor Study for at-Home GenViro! Saliva Swift :10 Test Kit
2020-12-10 09:28U:DECNNews ReleaseDECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK
2020-12-01 10:22U:DECNNews ReleaseDECN Announces Significant Agreement With Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as Well as Its Venerable GenUltimate! Blood Glucose Products
2020-11-23 09:19U:DECNNews ReleaseDECN XPRIZE Testing Data for Rapid COVID-19 Testing Technology Yields Near Textbook Results
2020-11-12 09:20U:DECNNews ReleaseDECN GenViro! Trial Using Human Saliva Donors for Its Swift Test Kits Proceeds Directly to FDA Level Testing As COVID-19 Product Testing Enters “Home Stretch ”
2020-11-06 10:15U:DECNNews ReleaseDECN Continues to Add GenViro! Dealers With an Agreement Covering Puerto Rico, the Dominican Republic, the US Virgin Islands and Geographies Across the Caribbean and Central America
2020-11-03 09:19U:DECNNews ReleaseDECN Announces Additional Distribution Agreement With a Distributor and Dealers in Nigeria, Ivory Coast and Lebanon
2020-10-19 09:16U:DECNNews ReleaseDECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits
2020-10-13 10:16U:DECNNews ReleaseDECN Provides Progress Update on Major Events for Its GenViro! Saliva Swift Kits for the Detection of COVID-19
2020-10-05 23:45U:DECNNews ReleaseDECN Enters into a New 6 Month $300,000 Promissory Note with Major Current Investor to Help Fund the Recent International Launch if its GenViro! Swift Kits
2020-10-02 10:16U:DECNNews ReleaseDECN Receives Significant Initial Order for International GenViro! Saliva Swift Kits for the Detection of COVID-19
2020-09-30 09:15U:DECNNews ReleaseDECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions
2020-09-22 09:16U:DECNNews ReleaseDECN Announces Completion of Critical Instructional Videos for its GenViro! Saliva Swift Kit for USA and International Professional Use
2020-09-18 09:16U:DECNNews ReleaseDECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing
2020-09-15 00:06U:DECNNews ReleaseDECN Enters into an Additional 6 Month $300,000 Promissory Note With Major Current Investor to Further Assist Launch of Genviro Swift Kits for the Detection of the Covid-19 Virus
2020-09-01 09:11U:DECNNews ReleaseDECN to Launch Its International Version GenViro! Saliva Swift :10.5 Second Covid-19 Kits on September 26, Will Then Accept Orders from Its Asian Distributor
2020-08-26 10:21U:DECNNews ReleaseDECN Provides Update on Accomplishments and Pathway to Securing FDA EUA Approval for its COVID-19 "Transmission Indicating Testing" Methodology
2020-08-10 10:20U:DECNNews ReleaseDECN CEO Releases Open Letter on FDA At-Home COVID-19 Rapid Testing Guidelines Saying It's the Speed to Results Reporting and Certain Added Regulations That Need to Be Addressed
2020-08-07 16:05U:DECNNews ReleaseDECN Publicly Disavows Covid-19 Swift Kit Video as Produced by Outside Unauthorized Party
2020-08-03 10:20U:DECNNews ReleaseDECN Issues Support for Recently Announced FDA COVID-19 At-Home Testing Template as the Company's Submission for Its Genviro! Swift COVID-19 At-Home Test Kit Anticipated Many of the New FDA Requisites
2020-07-23 09:16U:DECNNews ReleaseDECN Readies its GenViro! Covid-19 Swift Kits for Latest FDA Mandated Testing of both Saliva and Blood Protocols as it Enters Final Selection Process for a U.S. Based Testing Partner
2020-07-17 09:16U:DECNNews ReleaseDECN Says its Newest GenViro! COVID-19 Swift Kit Saliva Testing Option Can Play an Extensive Role in the Re-Opening of Schools as Company Awaits FDA Authorization
2020-07-10 10:24U:DECNNews ReleaseDECN to add GenViro! Saliva Covid-19 Swift Kit :10.5 for Professional and Home Use Testing, Providing an Alternative Modality to its Finger Stick Methodology
2020-07-08 09:16U:DECNNews ReleaseDECN Announces Distribution Agreement Covering GenViro! Covid-19:10.5 Swift Kits and Its GenUltimate and TGB Products in India, Malaysia, Sri Lanka, Singapore, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia
2020-07-02 10:16U:DECNNews ReleaseDECN CEO Offers Open Letter on COVID-19 Testing Highlighting Needed Support for Innovation in Testing
2020-06-17 10:25U:DECNNews ReleaseDECN Files Provisional Patent For GenViro! Professional COVID-19 :15 Swift Kit, Adds Enhanced Technology To Allow For Even Swifter Results
2020-06-12 10:24U:DECNNews ReleaseDECN Readies Its 2nd EUA Amendment With The FDA For Its GenViro! Swift Professional COVID-19 :15 Test Kit, And Also Announces Its Further Support For More And Continued Worldwide COVID-19 Testing
2020-06-04 09:11U:DECNNews ReleaseDECN CEO Interviewed On Vancouver's #1 News/Talk Radio Station, Discusses GenViro! Covid-19 :15 Swift Test Kit, Additional Interviews Anticipated
2020-05-21 10:15U:DECNNews ReleaseDECN to Publish Specific Testing Completed on its GenViro! Covid-19 :15 Swift Test Kits for Viewing by Shareholders and Other Interested Parties